Evidence map›Paper›PMID 38874380›Full record

ArticleEpilepsia open2024

Validity of the MoCA as a cognitive screening tool in epilepsy: Are there implications for global care and research?

Anny Reyes, Bruce P Hermann, Divya Prabhakaran, Lisa Ferguson, Dace N Almane, Jerry J Shih, Vicente J Iragui-Madoz, Aaron Struck, Vineet Punia, Jana E Jones and 2 more

Abstract readValidation Study
In one paragraph

Article in Epilepsia open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Resting-state EEG markers of cognitive dysfunction in epilepsy: evidence from gamma power, alpha activity, and functional connectivity.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. A user's guide for the International Classification of Cognitive Disorders in Epilepsy.Epileptic disorders : international epilepsy journal with videotape · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anny ReyesDepartment of Radiation Medicine & Applied Sciences, University of California, San Diego, California, USA.ORCID https://orcid.org/0000-0003-0625-6990
Bruce P HermannDepartment of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0003-0133-4427
Divya PrabhakaranDepartment of Radiation Medicine & Applied Sciences, University of California, San Diego, California, USA.
Lisa FergusonEpilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Dace N AlmaneDepartment of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Jerry J ShihDepartment of Neuroscience, University of California, San Diego, California, USA.
Vicente J Iragui-MadozDepartment of Neuroscience, University of California, San Diego, California, USA.
Aaron StruckDepartment of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Vineet PuniaEpilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-0552-6736
Jana E JonesDepartment of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Robyn M BuschEpilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-5442-4912
Carrie R McDonaldDepartment of Radiation Medicine & Applied Sciences, University of California, San Diego, California, USA.

Funding

BRain Aging and Cognition in Epilepsy (BRACE): A longitudinal investigationof vascular, genetic, and biomarker risk profiles in elderly patients with epilepsyR01NS120976 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CARRIE R MCDONALD · 2021 to 2026
$4.1M
Stroke Connectome MRI Biomarkers for VCID Risk AssessmentR01NS123378 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Nagesh Adluru, Veena A Nair · 2022 to 2026
$3.6M
Multimodal imaging of memory in epilepsy from whole brain networks to local neuronal responses: Implications for surgical decision-makingR01NS124585 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCDONALD, CARRIE R · 2022 to 2025
$3.3M
The Juvenile Myoclonic Epilepsy Connectome ProjectR01NS111022 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI STRUCK, AARON F · 2020 to 2024
$3.1M
PET/MR Correlates of Accelerated Aging in Chronic EpilepsyR01NS117568 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Alan Blair McMillan, Vivek Prabhakaran · 2021 to 2026
$3.0M
Burroughs Wellcome FundNational Academy of NeuropsychologyNIH HHS R01-NS111022NIH HHS R01-NS117568NIH HHS R01NS120976NIH HHS R01NS123378NINDS NIH HHS L60 NS134003NINDS NIH HHS R01 NS111022NINDS NIH HHS R01 NS117568NINDS NIH HHS R01 NS120976NINDS NIH HHS R01 NS123378NINDS NIH HHS R01 NS124585
6 · The paper itself

Abstract

objectiveThis study evaluated the diagnostic performance of a widely available cognitive screener, the Montreal cognitive assessment (MoCA), to detect cognitive impairment in older patients (age ≥ 55) with epilepsy residing in the US, using the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) as the gold standard.

methodsFifty older adults with focal epilepsy completed the MoCA and neuropsychological measures of memory, language, executive function, and processing speed/attention. The IC-CoDE taxonomy divided participants into IC-CoDE Impaired and Intact groups. Sensitivity and specificity across several MoCA cutoffs were examined. Spearman correlations examined relationships between the MoCA total score and clinical and demographic variables and MoCA domain scores and individual neuropsychological tests.

resultsIC-CoDE impaired patients demonstrated significantly lower scores on the MoCA total, visuospatial/executive, naming, language, delayed recall, and orientation domain scores (Cohen's d range: 0.336-2.77). The recommended MoCA cutoff score < 26 had an overall accuracy of 72%, 88.2% sensitivity, and 63.6% specificity. A MoCA cutoff score < 24 yielded optimal sensitivity (70.6%) and specificity (78.8%), with overall accuracy of 76%. Higher MoCA total scores were associated with greater years of education (p = 0.016) and fewer antiseizure medications (p = 0.049). The MoCA memory domain was associated with several standardized measures of memory, MoCA language domain with category fluency, and MoCA abstraction domain with letter fluency. SIGNIFICANCE: This study provides initial validation of the MoCA as a useful screening tool for older adults with epilepsy that can be used to identify patients who may benefit from comprehensive neuropsychological testing. Further, we demonstrate that a lower cutoff (i.e., <24) better captures cognitive impairment in older adults with epilepsy than the generally recommended cutoff and provides evidence for construct overlap between MoCA domains and standard neuropsychological tests. Critically, similar efforts in other regions of the world are needed. PLAIN LANGUAGE SUMMARY: The Montreal cognitive assessment (MoCA) can be a helpful tool to screen for cognitive impairment in older adults with epilepsy. We recommend that adults 55 or older with epilepsy who score less than 24 on the MoCA are referred to a neuropsychologist for a comprehensive evaluation to assess any changes in cognitive abilities and mood.

Indexed as

Cognitive DysfunctionEpilepsyMental Status and Dementia TestsNeuropsychological TestsAgedAged, 80 and overExecutive FunctionFemaleHumansMaleMiddle AgedReproducibility of ResultsSensitivity and Specificityagingcognitive screenerscognitive taxonomyglobal neuropsychology

Identifiers

PMID38874380
PMCPMC11296095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.